[HTML][HTML] The roles of Eph receptors, neuropilin-1, P2X7, and CD147 in COVID-19-associated neurodegenerative diseases: inflammasome and JaK inhibitors as …

H Zalpoor, A Akbari, A Samei… - Cellular & Molecular …, 2022 - Springer
The novel coronavirus disease 2019 (COVID-19) pandemic has spread worldwide, and
finding a safe therapeutic strategy and effective vaccine is critical to overcoming severe …

[HTML][HTML] Lectins and lectibodies: potential promising antiviral agents

M Nabi-Afjadi, M Heydari, H Zalpoor, I Arman… - Cellular & Molecular …, 2022 - Springer
In nature, lectins are widely dispersed proteins that selectively recognize and bind to
carbohydrates and glycoconjugates via reversible bonds at specific binding sites. Many viral …

[HTML][HTML] Hesperetin as an anti-SARS-CoV-2 agent can inhibit COVID-19-associated cancer progression by suppressing intracellular signaling pathways

H Zalpoor, M Bakhtiyari, H Shapourian… - …, 2022 - Springer
Hesperetin, an aglycone metabolite of hesperidin with high bioavailability, recently gained
attention due to its anti-COVID-19 and anti-cancer properties. Multiple studies revealed that …

Platelet-leukocyte crosstalk in COVID-19: How might the reciprocal links between thrombotic events and inflammatory state affect treatment strategies and disease …

M Ghasemzadeh, J Ahmadi, E Hosseini - Thrombosis research, 2022 - Elsevier
Platelet-leukocyte crosstalk is commonly manifested by reciprocal links between thrombosis
and inflammation. Platelet thrombus acts as a reactive matrix that recruits leukocytes to the …

The potential role of COVID-19 in progression, chemo-resistance, and tumor recurrence of oral squamous cell carcinoma (OSCC)

A Norouzi, M Liaghat, M Bakhtiyari… - Oral Oncology, 2023 - Elsevier
Numerous studies have revealed that cancer patients are more likely to develop severe
Coronavirus disease-2019 (COVID-19), which can cause mortality, as well as cancer …

[HTML][HTML] SARS-CoV-2 infection and dysregulation of nuclear factor erythroid-2-related factor 2 (Nrf2) pathway

RS Hamad, HM Al-Kuraishy, A Alexiou… - Cell Stress and …, 2023 - Elsevier
Abstract Coronavirus disease 2019 (COVID-19) is a recent pandemic caused by a novel
severe acute respiratory syndrome coronavirus 2 (SARS‑CoV‑2) leading to pulmonary and …

[HTML][HTML] Ephrin (Eph) receptor and downstream signaling pathways: a promising potential targeted therapy for COVID‑19 and associated cancers and diseases

H Zalpoor, A Akbari, M Nabi-Afjadi - Human Cell, 2022 - Springer
Currently, the coronavirus disease 2019 (COVID-19) pandemic has become a serious
concern to the worldwide healthcare system. Severe acute respiratory syndrome …

Targeting ATP2B1 impairs PI3K/Akt/FOXO signaling and reduces SARS-COV-2 infection and replication

P de Antonellis, V Ferrucci, M Miceli, F Bibbo… - EMBO …, 2024 - embopress.org
ATP2B1 is a known regulator of calcium (Ca2+) cellular export and homeostasis.
Diminished levels of intracellular Ca2+ content have been suggested to impair SARS-CoV-2 …

[HTML][HTML] Shared miRNA landscapes of COVID-19 and neurodegeneration confirm neuroinflammation as an important overlapping feature

S Redenšek Trampuž, D Vogrinc, K Goričar… - Frontiers in molecular …, 2023 - frontiersin.org
Introduction: Development and worsening of most common neurodegenerative diseases,
such as Alzheimer's disease, Parkinson's disease, and multiple sclerosis, have been …

[HTML][HTML] A machine learning method for the identification and characterization of novel COVID-19 drug targets

B Schultz, LN DeLong, A Masny, M Lentzen… - Scientific Reports, 2023 - nature.com
In addition to vaccines, the World Health Organization sees novel medications as an urgent
matter to fight the ongoing COVID-19 pandemic. One possible strategy is to identify target …